BioSig Technologies, Inc. STEX Proceeds From Issuance Of Sale Of Equity
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept STEX:ProceedsFromIssuanceOfSaleOfEquity.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s proceeds from issuance of sale of equity.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s proceeds from issuance of sale of equity?
- BioSig Technologies, Inc. (STEX) reported proceeds from issuance of sale of equity of $225K in Q1 2026.